attenuated H5N1 avian influenza virus vaccine

The attenuated H5N1 avian influenza virus vaccine is a prophylactic biologic designed to induce protective immunity against the H5N1 strain of avian influenza. In clinical contexts such as the FLU-PPV-S study in Japan, these vaccines utilize specific viral strains, including A/Anhui/01/2005 and A/Indo/5/2005, which are often reverse genetics-derived to reduce pathogenicity while maintaining immunogenicity. The vaccine is typically administered as a two-dose intramuscular regimen to healthy adults to evaluate the durability of the immune response and the potential for cross-immunity against variant H5N1 strains. Its primary mechanism involves stimulating the production of neutralizing antibodies against the viral hemagglutinin (HA) protein, thereby preventing severe respiratory illness and systemic infection in the event of a pandemic outbreak.

Other names

attenuated H5N1 avian influenza virus vaccine (A/Anhui/01/2005)attenuated H5N1 avian influenza virus vaccine (A/Indo/5/2005)H5N1 influenza vaccine (A/Anhui/01/2005)H5N1 influenza vaccine (A/Indo/5/2005)